Sorrento Therapeutics Inc. (SRNE) News Nov 20, 2014, 4:00 p.m.
MarketWatch News on SRNE
No News currently available for SRNE
Other News on SRNE
10-Q: SORRENTO THERAPEUTICS, INC. 2:50 p.m. Nov. 4, 2014 - Edgar Online - (EDG = 10Q, 10K)
Week In Review: Lee's Pharm Pays $50 Million For Novel Cancer Drug From Sorrento 10:50 a.m. Oct. 13, 2014 - Seeking Alpha
Sorrento out-licenses anti-PDL1 mAb 3:46 p.m. Oct. 6, 2014 - Seeking Alpha
Following Biotech Stocks After Price Declines Of Greater Than 50% 3:03 p.m. Sept. 25, 2014 - Seeking Alpha
Sorrento's MYC Inhibitor Demonstrates Promising Potential For Cancer Treatment 12:18 p.m. Aug. 20, 2014 - Seeking Alpha
10-Q: SORRENTO THERAPEUTICS, INC. 4:13 p.m. Aug. 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
Sorrento secures NIH grants 1:02 p.m. July 1, 2014 - Seeking Alpha
Why Sorrento Therapeutics (SRNE) Stock Plummeted Today 3:06 p.m. May 15, 2014 - TheStreet.com
10-Q: SORRENTO THERAPEUTICS, INC. 3:15 p.m. May 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Sorrento completes a roundtrip 11:20 a.m. April 8, 2014 - Seeking Alpha
10-K: SORRENTO THERAPEUTICS, INC. 5:09 a.m. April 1, 2014 - Edgar Online - (EDG = 10Q, 10K)
Sorrento starts animal health group 7:08 a.m. March 25, 2014 - Seeking Alpha
Sorrento Therapeutics (SRNE) Soars: Stock Up 8.6% - Tale of the Tape 9:39 a.m. March 6, 2014 - Zacks.com
Sorrento (SRNE) Jumps: Stock Adds 11.0% in Session - Tale of the Tape 9:46 a.m. Feb. 28, 2014 - Zacks.com
Big Pharma Will Find Good Hunting Among Early-Stage Biotechs: Dhesh Govender 11:56 a.m. Feb. 14, 2014 - Seeking Alpha
Sorrento Therapeutics (SRNE) Jumps: Stock Adds 9.1% in Session - Tale of the Tape 8:51 a.m. Jan. 23, 2014 - Zacks.com
Sorrento Therapeutics: Has The Potential To Become Next Abraxis 1:52 p.m. Jan. 7, 2014 - Seeking Alpha
Opportunities For Sorrento After Acquisition Of ADC Tech 2:21 p.m. Dec. 3, 2013 - Seeking Alpha
Healthcare initiations for Tuesday 10:28 a.m. Dec. 3, 2013 - Seeking Alpha
Healthcare downgrades and initiations for Thursday 9:29 a.m. Nov. 21, 2013 - Seeking Alpha
Press Releases on SRNE
Sorrento To Present At The 2014 Stifel Healthcare Conference 11:00 a.m. Nov. 12, 2014 - PR Newswire - PRF
BTV Episode #300 Featuring Gilead, Cynapsus and biOasis 6:04 a.m. Nov. 6, 2014 - Marketwired
Initial Pharmacokinetic Data From TRIBECA Study Support Potential For Bioequivalence Between Cynviloq And Albumin-Bound Paclitaxel 3:00 p.m. Oct. 14, 2014 - PR Newswire - PRF
Sorrento and Lee's Pharmaceutical Enter into Exclusive China Licensing Agreement to Develop and Commercialize Anti-PD-L1 antibody 1:41 p.m. Oct. 3, 2014 - PR Newswire - PRF
Sorrento Therapeutics to Present at Two Healthcare Conferences 7:45 a.m. Sept. 5, 2014 - PR Newswire - PRF
Sorrento Awarded NIH Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF) 7:45 a.m. Aug. 26, 2014 - PR Newswire - PRF
Data Published by Researchers from The Scripps Research Institute Demonstrate Potential for MYC Inhibitor Licensed by Sorrento Therapeutics 6:45 a.m. Aug. 18, 2014 - PR Newswire - PRF
Sorrento Therapeutics Appoints Douglas Ebersole to its Board of Directors 4:00 p.m. Aug. 8, 2014 - PR Newswire - PRF
Sorrento Announces the Unexpected Death of its Chief Business Officer 4:38 p.m. July 31, 2014 - PR Newswire - PRF
Sorrento Awarded up to $2.6 Million from the National Institutes of Health (NIH) for the Development of New Anti-bacterial Bispecific Antibodies and Antibody Formulated Drug Conjugates 7:45 a.m. July 1, 2014 - PR Newswire - PRF
BTV Reports on Roche, Sorrento Therapeutics Takes on a Goliath, Plus Biotech Up-and-Comers 5:02 a.m. June 26, 2014 - Marketwire
Morphotek and Sorrento Therapeutics Sign an Exclusive Research and Option Agreement to Generate and Develop Morphotek Antibody Drug Conjugates 7:45 a.m. June 25, 2014 - PR Newswire - PRF
Sorrento Therapeutics Announces Confidential Submission of Draft Registration Statement for Initial Public Offering (IPO) of its Wholly-owned Subsidiary Ark Animal Health with the SEC 7:45 a.m. June 23, 2014 - PR Newswire - PRF
Sorrento to Present at BIO Business Forum 2:15 p.m. June 20, 2014 - PR Newswire - PRF
Sorrento Announces Underwriters' Exercise of Over-Allotment Option 7:30 p.m. June 12, 2014 - PR Newswire - PRF
Sorrento Therapeutics to Present at Jefferies 2014 Global Healthcare Conference 12:49 p.m. May 30, 2014 - PR Newswire - PRF
Sorrento Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock 10:57 p.m. May 14, 2014 - PR Newswire - PRF
Sorrento Therapeutics, Inc. Announces Proposed Public Offering of Common Stock 3:40 p.m. May 14, 2014 - PR Newswire - PRF
Sorrento Announces Transfer of Orphan Drug Designation Sponsorship for Intrathecal Resiniferatoxin from NIH 6:30 a.m. May 13, 2014 - PR Newswire - PRF
Oxford Finance and Silicon Valley Bank Expand Existing Senior Credit Facility with Sorrento Therapeutics to $12.5 Million 9:00 a.m. April 16, 2014 - PR Newswire - PRF
MarketWatch News on SRNE
No News currently available for SRNE
Other News on SRNE
10-Q: SORRENTO THERAPEUTICS, INC. 2:50 p.m. Nov. 4, 2014 - Edgar Online - (EDG = 10Q, 10K)
Week In Review: Lee's Pharm Pays $50 Million For Novel Cancer Drug From Sorrento 10:50 a.m. Oct. 13, 2014 - Seeking Alpha
Sorrento out-licenses anti-PDL1 mAb 3:46 p.m. Oct. 6, 2014 - Seeking Alpha
Following Biotech Stocks After Price Declines Of Greater Than 50% 3:03 p.m. Sept. 25, 2014 - Seeking Alpha
Sorrento's MYC Inhibitor Demonstrates Promising Potential For Cancer Treatment 12:18 p.m. Aug. 20, 2014 - Seeking Alpha
10-Q: SORRENTO THERAPEUTICS, INC. 4:13 p.m. Aug. 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
Sorrento secures NIH grants 1:02 p.m. July 1, 2014 - Seeking Alpha
Why Sorrento Therapeutics (SRNE) Stock Plummeted Today 3:06 p.m. May 15, 2014 - TheStreet.com
10-Q: SORRENTO THERAPEUTICS, INC. 3:15 p.m. May 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Sorrento completes a roundtrip 11:20 a.m. April 8, 2014 - Seeking Alpha
10-K: SORRENTO THERAPEUTICS, INC. 5:09 a.m. April 1, 2014 - Edgar Online - (EDG = 10Q, 10K)
Sorrento starts animal health group 7:08 a.m. March 25, 2014 - Seeking Alpha
Sorrento Therapeutics (SRNE) Soars: Stock Up 8.6% - Tale of the Tape 9:39 a.m. March 6, 2014 - Zacks.com
Sorrento (SRNE) Jumps: Stock Adds 11.0% in Session - Tale of the Tape 9:46 a.m. Feb. 28, 2014 - Zacks.com
Big Pharma Will Find Good Hunting Among Early-Stage Biotechs: Dhesh Govender 11:56 a.m. Feb. 14, 2014 - Seeking Alpha
Sorrento Therapeutics (SRNE) Jumps: Stock Adds 9.1% in Session - Tale of the Tape 8:51 a.m. Jan. 23, 2014 - Zacks.com
Sorrento Therapeutics: Has The Potential To Become Next Abraxis 1:52 p.m. Jan. 7, 2014 - Seeking Alpha
Opportunities For Sorrento After Acquisition Of ADC Tech 2:21 p.m. Dec. 3, 2013 - Seeking Alpha
Healthcare initiations for Tuesday 10:28 a.m. Dec. 3, 2013 - Seeking Alpha
Healthcare downgrades and initiations for Thursday 9:29 a.m. Nov. 21, 2013 - Seeking Alpha
Press Releases on SRNE
Sorrento To Present At The 2014 Stifel Healthcare Conference 11:00 a.m. Nov. 12, 2014 - PR Newswire - PRF
BTV Episode #300 Featuring Gilead, Cynapsus and biOasis 6:04 a.m. Nov. 6, 2014 - Marketwired
Initial Pharmacokinetic Data From TRIBECA Study Support Potential For Bioequivalence Between Cynviloq And Albumin-Bound Paclitaxel 3:00 p.m. Oct. 14, 2014 - PR Newswire - PRF
Sorrento and Lee's Pharmaceutical Enter into Exclusive China Licensing Agreement to Develop and Commercialize Anti-PD-L1 antibody 1:41 p.m. Oct. 3, 2014 - PR Newswire - PRF
Sorrento Therapeutics to Present at Two Healthcare Conferences 7:45 a.m. Sept. 5, 2014 - PR Newswire - PRF
Sorrento Awarded NIH Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF) 7:45 a.m. Aug. 26, 2014 - PR Newswire - PRF
Data Published by Researchers from The Scripps Research Institute Demonstrate Potential for MYC Inhibitor Licensed by Sorrento Therapeutics 6:45 a.m. Aug. 18, 2014 - PR Newswire - PRF
Sorrento Therapeutics Appoints Douglas Ebersole to its Board of Directors 4:00 p.m. Aug. 8, 2014 - PR Newswire - PRF
Sorrento Announces the Unexpected Death of its Chief Business Officer 4:38 p.m. July 31, 2014 - PR Newswire - PRF
Sorrento Awarded up to $2.6 Million from the National Institutes of Health (NIH) for the Development of New Anti-bacterial Bispecific Antibodies and Antibody Formulated Drug Conjugates 7:45 a.m. July 1, 2014 - PR Newswire - PRF
BTV Reports on Roche, Sorrento Therapeutics Takes on a Goliath, Plus Biotech Up-and-Comers 5:02 a.m. June 26, 2014 - Marketwire
Morphotek and Sorrento Therapeutics Sign an Exclusive Research and Option Agreement to Generate and Develop Morphotek Antibody Drug Conjugates 7:45 a.m. June 25, 2014 - PR Newswire - PRF
Sorrento Therapeutics Announces Confidential Submission of Draft Registration Statement for Initial Public Offering (IPO) of its Wholly-owned Subsidiary Ark Animal Health with the SEC 7:45 a.m. June 23, 2014 - PR Newswire - PRF
Sorrento to Present at BIO Business Forum 2:15 p.m. June 20, 2014 - PR Newswire - PRF
Sorrento Announces Underwriters' Exercise of Over-Allotment Option 7:30 p.m. June 12, 2014 - PR Newswire - PRF
Sorrento Therapeutics to Present at Jefferies 2014 Global Healthcare Conference 12:49 p.m. May 30, 2014 - PR Newswire - PRF
Sorrento Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock 10:57 p.m. May 14, 2014 - PR Newswire - PRF
Sorrento Therapeutics, Inc. Announces Proposed Public Offering of Common Stock 3:40 p.m. May 14, 2014 - PR Newswire - PRF
Sorrento Announces Transfer of Orphan Drug Designation Sponsorship for Intrathecal Resiniferatoxin from NIH 6:30 a.m. May 13, 2014 - PR Newswire - PRF
Oxford Finance and Silicon Valley Bank Expand Existing Senior Credit Facility with Sorrento Therapeutics to $12.5 Million 9:00 a.m. April 16, 2014 - PR Newswire - PRF
